4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001193125-26-279703
CEO and President bought 231,482 shares at $2.16 ($500,001)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Angel Matthew CEO and President | 2026-03-24 | Purchase | +231,482 | $2.16 | $500,001 | 231,482 | I |
| Derivatives | |||||||
| Angel Matthew CEO and President | 2026-03-24 | Purchase · Series A Warrant (right to buy) | +231,482 | 231,482 | I | ||
| Angel Matthew CEO and President | 2026-03-24 | Purchase · Series B Warrant (right to buy) | +231,482 | 231,482 | I | ||
| Open-market purchases · 231,482 sh · avg $2.16 · $500,001 | |||||||
Loading xslF345X06/ownership.xml…